Cargando…

canSAR: an integrated cancer public translational research and drug discovery resource

canSAR is a fully integrated cancer research and drug discovery resource developed to utilize the growing publicly available biological annotation, chemical screening, RNA interference screening, expression, amplification and 3D structural data. Scientists can, in a single place, rapidly identify bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Halling-Brown, Mark D., Bulusu, Krishna C., Patel, Mishal, Tym, Joe E., Al-Lazikani, Bissan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3245005/
https://www.ncbi.nlm.nih.gov/pubmed/22013161
http://dx.doi.org/10.1093/nar/gkr881
_version_ 1782219778178416640
author Halling-Brown, Mark D.
Bulusu, Krishna C.
Patel, Mishal
Tym, Joe E.
Al-Lazikani, Bissan
author_facet Halling-Brown, Mark D.
Bulusu, Krishna C.
Patel, Mishal
Tym, Joe E.
Al-Lazikani, Bissan
author_sort Halling-Brown, Mark D.
collection PubMed
description canSAR is a fully integrated cancer research and drug discovery resource developed to utilize the growing publicly available biological annotation, chemical screening, RNA interference screening, expression, amplification and 3D structural data. Scientists can, in a single place, rapidly identify biological annotation of a target, its structural characterization, expression levels and protein interaction data, as well as suitable cell lines for experiments, potential tool compounds and similarity to known drug targets. canSAR has, from the outset, been completely use-case driven which has dramatically influenced the design of the back-end and the functionality provided through the interfaces. The Web interface at http://cansar.icr.ac.uk provides flexible, multipoint entry into canSAR. This allows easy access to the multidisciplinary data within, including target and compound synopses, bioactivity views and expert tools for chemogenomic, expression and protein interaction network data.
format Online
Article
Text
id pubmed-3245005
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-32450052012-01-10 canSAR: an integrated cancer public translational research and drug discovery resource Halling-Brown, Mark D. Bulusu, Krishna C. Patel, Mishal Tym, Joe E. Al-Lazikani, Bissan Nucleic Acids Res Articles canSAR is a fully integrated cancer research and drug discovery resource developed to utilize the growing publicly available biological annotation, chemical screening, RNA interference screening, expression, amplification and 3D structural data. Scientists can, in a single place, rapidly identify biological annotation of a target, its structural characterization, expression levels and protein interaction data, as well as suitable cell lines for experiments, potential tool compounds and similarity to known drug targets. canSAR has, from the outset, been completely use-case driven which has dramatically influenced the design of the back-end and the functionality provided through the interfaces. The Web interface at http://cansar.icr.ac.uk provides flexible, multipoint entry into canSAR. This allows easy access to the multidisciplinary data within, including target and compound synopses, bioactivity views and expert tools for chemogenomic, expression and protein interaction network data. Oxford University Press 2012-01 2011-10-19 /pmc/articles/PMC3245005/ /pubmed/22013161 http://dx.doi.org/10.1093/nar/gkr881 Text en © The Author(s) 2011. Published by Oxford University Press. http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Articles
Halling-Brown, Mark D.
Bulusu, Krishna C.
Patel, Mishal
Tym, Joe E.
Al-Lazikani, Bissan
canSAR: an integrated cancer public translational research and drug discovery resource
title canSAR: an integrated cancer public translational research and drug discovery resource
title_full canSAR: an integrated cancer public translational research and drug discovery resource
title_fullStr canSAR: an integrated cancer public translational research and drug discovery resource
title_full_unstemmed canSAR: an integrated cancer public translational research and drug discovery resource
title_short canSAR: an integrated cancer public translational research and drug discovery resource
title_sort cansar: an integrated cancer public translational research and drug discovery resource
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3245005/
https://www.ncbi.nlm.nih.gov/pubmed/22013161
http://dx.doi.org/10.1093/nar/gkr881
work_keys_str_mv AT hallingbrownmarkd cansaranintegratedcancerpublictranslationalresearchanddrugdiscoveryresource
AT bulusukrishnac cansaranintegratedcancerpublictranslationalresearchanddrugdiscoveryresource
AT patelmishal cansaranintegratedcancerpublictranslationalresearchanddrugdiscoveryresource
AT tymjoee cansaranintegratedcancerpublictranslationalresearchanddrugdiscoveryresource
AT allazikanibissan cansaranintegratedcancerpublictranslationalresearchanddrugdiscoveryresource